|
Avaliação DCF GluCotrack, Inc. (GCTK)
IL | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
GlucoTrack, Inc. (GCTK) Bundle
Simplifique a avaliação GluCoTrack, Inc. (GCTK) com esta calculadora DCF personalizável! Com o Real GlucoTrack, Inc. (GCTK) e entradas de previsão ajustáveis, você pode testar cenários e descobrir o valor justo GlucoTrack, Inc. (GCTK) em minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -100 | 0 | 0 | 0 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -3.5 | -3.1 | -4.0 | -4.4 | -7.1 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -1654.99 | 100 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Depreciation | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 24.43 | 100 | 100 | 100 | 100 | 84.89 | 84.89 | 84.89 | 84.89 | 84.89 |
| EBIT | -3.5 | -3.1 | -4.0 | -4.4 | -7.1 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -1679.42 | 100 | 100 | 100 | 100 | 60 | 60 | 60 | 60 | 60 |
| Total Cash | .4 | 9.8 | 6.1 | 2.3 | 4.5 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 33.53 | 100 | 100 | 100 | 100 | 86.71 | 86.71 | 86.71 | 86.71 | 86.71 |
| Inventories | .2 | .3 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 88.43 | 100 | 100 | 100 | 100 | 97.69 | 97.69 | 97.69 | 97.69 | 97.69 |
| Accounts Payable | 1.5 | .9 | .6 | .7 | .8 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 734.81 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -11.22 | 100 | 100 | 100 | 100 | -2.24 | -2.24 | -2.24 | -2.24 | -2.24 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -3.5 | -3.0 | -4.1 | -4.4 | -7.1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2.2 | -3.8 | -3.9 | -4.4 | -6.9 | -.8 | .0 | .0 | .0 | .0 |
| WACC, % | 4.86 | 4.85 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | 3 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | 0.84 |
What You Will Get
- Comprehensive GCTK Financial Data: Pre-filled with GlucoTrack’s historical and projected data for thorough analysis.
- Fully Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA %.
- Instant Calculations: Observe GlucoTrack’s intrinsic value update in real-time as you make changes.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- User-Friendly Interface: Intuitive layout and straightforward instructions suitable for all skill levels.
Key Features
- Comprehensive GlucoTrack Data: Gain access to precise, pre-loaded historical performance metrics and future forecasts.
- Adjustable Forecast Parameters: Modify highlighted cells for key variables such as discount rates, growth assumptions, and profit margins.
- Real-Time Calculations: Automatic recalculations for Discounted Cash Flow (DCF), Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Intuitive charts and summaries that clearly present your valuation findings.
- Designed for All Levels: A straightforward, user-friendly layout tailored for investors, financial analysts, and consultants.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered GlucoTrack, Inc. (GCTK) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for GlucoTrack, Inc.'s (GCTK) intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose GlucoTrack, Inc. (GCTK) Calculator?
- Precision: Utilizes real GlucoTrack financial data for reliable outcomes.
- Versatility: Tailored for users to easily adjust and experiment with inputs.
- Efficiency: Eliminate the need to create a financial model from the ground up.
- Expert-Level: Crafted with the accuracy and usability expected by industry professionals.
- Intuitive: Simple to navigate, making it accessible for users without extensive financial expertise.
Who Should Use GlucoTrack, Inc. (GCTK)?
- Healthcare Professionals: Enhance patient monitoring with innovative glucose tracking solutions.
- Researchers: Utilize advanced data for studies on diabetes management and treatment efficacy.
- Investors: Evaluate market potential and growth opportunities within the diabetes care sector.
- Tech Enthusiasts: Explore cutting-edge technology in health monitoring and its applications.
- Diabetes Patients: Benefit from real-time glucose monitoring to improve daily health management.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for GlucoTrack, Inc. (GCTK).
- Real-World Data: GlucoTrack’s historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to GlucoTrack, Inc. (GCTK).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results regarding GlucoTrack, Inc. (GCTK).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.